The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-? and PD-L1 Pathways.
Birrer MJ, Fujiwara K, Oaknin A, Randall L, Ojalvo LS, Valencia C, Ray-Coquard I. The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-? and PD-L1 Pathways. Front Oncol. 2022; 12:814169.